Stack safety
Interaction analyzer.
Up to four compounds at a time. Each pair yields a grade based on shared pathway reach.
Pick up to 4 compounds. Each pair yields a grade based on shared pathway reach.
Pathway-based scoring only. Mechanistic plausibility, not clinical outcome data.
Tirzepatide✗Retatrutide
Avoid stacking
Both target GIP/GLP-1 with overlapping glucagon reach; receptor saturation documented in phase-2 cohorts.
Stack subjects: Tirzepatide · Retatrutide